Skip to content

Castle Biosciences CSTL Interest Income

Interest Income at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$12.2M+87.7%
Personalis, Inc. logo
Personalis, Inc.PSNL
$2.17M+7.2%
NeoGenomics logo
NeoGenomicsNEO
$1.27M-65.8%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$8.65M+7.9%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$7.61M+158%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$2.08M-22.4%

Segments

By segment

See full
Reportable Segment$2.55M-17.9%

Other financials

Income statement

See full
Revenue$83.7M-4.9%
Gross profit$63.1M-11.8%
Operating income-$18.4M+34.1%
Net income-$14.5M+43.8%
EPS (diluted)-$0.49+45.6%

Balance sheet

See full
Cash & equivalents$63.8M-28.9%
Total debt$36.7M+42.1%
Total equity$461.4M+4.8%
Total assets$547.8M+9.2%

Cash flow

See full
Operating cash flow-$22.1M-267%
CapEx$12.5M+163%
Free cash flow-$34.6M-221%

Valuation

See full
Market cap$694.86M+29.9%
Enterprise value$667.82M+41.8%
P/S+0.5×

Profitability

See full
Gross margin77.9%-4.1pp
Operating margin-9.8%-30.8pp
Net margin-3.8%-10.2pp
FCF margin1.3%-10.7pp

Returns & leverage

See full
Return on equity-2.8%-10.6pp
Debt / equity0.1×0.0×
Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Castle Biosciences's interest income?
Castle Biosciences (CSTL) reported interest income of $2.55M in Q1 2026.
How has Castle Biosciences's interest income changed year-over-year?
Castle Biosciences's interest income decreased by 17.9% year-over-year, from $3.1M to $2.55M.
What is the long-term trend for Castle Biosciences's interest income?
Over 4 years (2021 to 2025), Castle Biosciences's interest income has grown at a 262.7% compound annual growth rate (CAGR), from $68K to $11.77M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.